MDMA (Catalan Wikipedia)

«Duloxetine inhibits effects of MDMA ("ecstasy") in vitro and in humans in a randomized placebo-controlled laboratory study». PLOS ONE, vol. 7, 5, 04-05-2012, p. e36476. Bibcode: 2012PLoSO...736476H. DOI: 10.1371/journal.pone.0036476. PMC: 3344887. PMID: 22574166.
«Sleep loss and acute drug abuse can induce DNA damage in multiple organs of mice». Human & Experimental Toxicology, vol. 30, 9, 9-2011, p. 1275–1281. Bibcode: 2011HETox..30.1275A. DOI: 10.1177/0960327110388535. PMID: 21071548.
«Verbal Memory Impairment in Polydrug Ecstasy Users: A Clinical Perspective». PLOS ONE, vol. 11, 2, p. e0149438. Bibcode: 2016PLoSO..1149438K. DOI: 10.1371/journal.pone.0149438. PMC: 4764468. PMID: 26907605.
«Farmacologia de l'MDMA en humans». Annals of the New York Academy of Sciences, vol. 914, 1, 9-2000, p. 225–37. Bibcode: 2000NYASA.914..225D. DOI: 10.1111/j.1749-6632.2000.tb05199.x. PMID: 11085324.

amazon.com (Global: 159^th place; Catalan: 306^th place)

«Molly Madness». Drogues, Inc. (documental de televisió) (National Geographic Channel). 2014-08-13. ASIN B00LIC368M.
«Manic Molly». Drogues, Inc. (documental de televisió) (National Geographic Channel). 2014-12-10. ASIN B00LIC368M.

apnews.com (Global: 101^st place; Catalan: 341^st place)

«DEA To Ban "Ecstasy" – The Drug MDMA». The Associated Press, 30-05-1985.

archive.org (Global: 6^th place; Catalan: 15^th place)

«Pharmacological Effects of MDMA in Man». A: Pharmacology and Abuse of Cocaine, Amphetamines, Ecstasy and Related Designer Drugs. Springer Netherlands, 2009-07-28, p. 151–160. DOI 10.1007/978-90-481-2448-0_24. ISBN 978-90-481-2448-0.
«Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms». Brain Research. Brain Research Reviews, vol. 42, 2. DOI: 10.1016/S0165-0173(03)00173-5. PMID: 12738056.
«Gender differences in the subjective effects of MDMA». Psychopharmacology, vol. 154, 2, 3-2001, p. 161–8. DOI: 10.1007/s002130000648. PMID: 11314678.
«What does MDMA feel like?». A: Ecstasy: The complete guide. A comprehensive look at the risks and benefits of MDMA.. Rochester: Park Street Press, 2001.
«Ecstasy: pharmacodynamic and pharmacokinetic interactions». Psychosomatics, vol. 45, 1, 01-03-2004, p. 84–87. DOI: 10.1176/appi.psy.45.1.84. PMID: 14709765.
«Ecstacy: a review of MDMA and MDA». International Journal of Psychiatry in Medicine, vol. 16, 4, 1986, p. 359–72. DOI: 10.2190/dcrp-u22m-aumd-d84h. PMID: 2881902.
«New age seekers: MDMA use as an adjunct to spiritual pursuit». Journal of Psychoactive Drugs, vol. 23, 3, 1991, p. 261–70. DOI: 10.1080/02791072.1991.10471587. PMID: 1685513.
«Èxtasi (MDMA) i funció de la memòria: una actualització meta-analítica». Human Psychopharmacology, vol. 22, 6, 8-2007, p. 381–8. DOI: 10.1002/hup.857. PMID: 17621368.
Human biology. 10a. Belmont, CA: Brooks/Cole Cengage Learning, 2014. ISBN 978-1-133-59916-6.
«Development of a rational scale to assess the harm of drugs of potential misuse». Lancet, vol. 369, 9566, 3-2007, p. 1047–1053. DOI: 10.1016/S0140-6736(07)60464-4. PMID: 17382831.
Nota de premsa: «Scientists want new drug rankings». Notícies de la BBC, 23-03-2007.
«Acute toxic effects of 'Ecstasy' (MDMA) and related compounds: overview of pathophysiology and clinical management». British Journal of Anaesthesia, vol. 96, 6, 6-2006, p. 678–85. DOI: 10.1093/bja/ael078. PMID: 16595612.
Manual d'Atenció Crítica Americana d'Oxford. Oxford University Press, 2008, p. 464. ISBN 978-0-19-530528-9. OCLC 1003197730.
«3,4-methylenedioxyamfetamine (ecstasy) use reduces cognition». British Journal of Nursing, vol. 19, 2, 2010, p. 94–100. PMID: 20235382.
«Death following ingestion of MDMA (ecstasy) and moclobemide». Addiction, vol. 98, 3, 3-2003, p. 365–8. DOI: 10.1046/j.1360-0443.2003.00292.x. PMID: 12603236.
«Quins neurotransmissors medien els efectes subjectius de l'MDMA en humans? Un resum dels estudis mecanístics». Human Psychopharmacology, vol. 16, 8, 12-2001, p. 589–598. DOI: 10.1002/hup.348. PMID: 12404538.
«Efectes cardiovasculars i neuroendocrins i farmacocinètica de la 3,4-metilendioximetanfetamina en humans». The Journal of Pharmacology and Experimental Therapeutics, vol. 290, 1, 7-1999, p. 136–45. PMID: 10381769.
«Farmacocinètica no lineal de l'MDMA ('èxtasi') en humans». British Journal of Clinical Pharmacology, vol. 49, 2, 2-2000, p. 104–9. DOI: 10.1046/j.1365-2125.2000.00121.x. PMC: 2014905. PMID: 10671903.
«Anàlisi estereoespecífica i disposició enantiomèrica de la 3,4-metilèndioximetanfetamina (Èxtasi) en humans». Clinical Chemistry, vol. 45, 7, 7-1999, p. 1058–69. DOI: 10.1093/clinchem/45.7.1058. PMID: 10388483.
«A study of the precursors, intermediates and reaction by-products in the synthesis of 3,4-methylenedioxymethylamphetamine and its application to forensic drug analysis». Forensic Science International, vol. 60, 3, 8-1993, p. 189–202. DOI: 10.1016/0379-0738(93)90238-6. PMID: 7901132.
«Disposition of MDMA and metabolites in human sweat following controlled MDMA administration». Química Clínica, vol. 55, 3, 3-2009, p. 454–62. DOI: 10.1373/clinchem.2008.117093. PMC: 2669283. PMID: 19168553.
Disposició de drogues tòxiques i productes químics en l'home. 9a. Seal Beach, Califòrnia: Publicacions Biomèdiques, 2011, p. 1078–1080. ISBN 978-0-9626523-8-7.
«Rediscovering MDMA (ecstasy): the role of the American chemist Alexander T. Shulgin». Addiction, vol. 105, 8, 8-2010, p. 1355–61. DOI: 10.1111/j.1360-0443.2010.02948.x. PMID: 20653618.
«An exploration of the history and controversies surrounding MDMA and MDA». Journal of Psychoactive Drugs, vol. 33, 3, 2001, p. 213–21. DOI: 10.1080/02791072.2001.10400568. PMID: 11718314.
«The Distribution of Ecstasy». A: Pursuit of Ecstasy : The MDMA Experience. Albany: State Univ. of New York Press, 1994. ISBN 978-0-7914-1817-8.
«Chapter 6: Why MDMA Should Not Have Been Made Illegal». A: The Drug Legalization Debate. 2nd. Londres: SAGE Publications, 1991. ISBN 978-0-8039-3678-2.
Renfroe, CL «MDMA on the street: Analysis Anonymous». Journal of Psychoactive Drugs, 18, 4, 10-1986, p. 363–9. DOI: 10.1080/02791072.1986.10472371.
«The History of MDMA». A: Ecstasy: the complete guide; a comprehensive look at the risks and benefits of MDMA. Park Street Press, 2001. ISBN 978-0-89281-857-0.
«Ecstasy use among US adolescents from 1999 to 2008». Drug and Alcohol Dependence, vol. 112, 1–2, 11-2010, p. 33–8. DOI: 10.1016/j.drugalcdep.2010.05.006. PMC: 2967577. PMID: 20570447.

archives-ouvertes.fr (Global: 1,143^rd place; Catalan: 1,180^th place)

hal.archives-ouvertes.fr

«Challenges with benchmarking of MDMA-assisted psychotherapy». . DOI: 10.1038/s41591-021-01525-0. PMID: 34635857.

bbc.co.uk (Global: 11^th place; Catalan: 21^st place)

news.bbc.co.uk

«Development of a rational scale to assess the harm of drugs of potential misuse». Lancet, vol. 369, 9566, 3-2007, p. 1047–1053. DOI: 10.1016/S0140-6736(07)60464-4. PMID: 17382831.
Nota de premsa: «Scientists want new drug rankings». Notícies de la BBC, 23-03-2007.
«Why ecstasy is 'vanishing' from UK nightclubs». BBC News, 19-01-2010.

bbc.co.uk

«Ecstasy on Prescription». BBC Business Daily, 29-05-2018.

books.google.cat (Global: 516^th place; Catalan: 3^rd place)

World Health Organization. Neuroscience of Psychoactive Substance Use and Dependence. World Health Organization, 2004, p. 97–. ISBN 978-92-4-156235-5.
Pharmacology and Abuse of Cocaine, Amphetamines, Ecstasy and Related Designer Drugs: A comprehensive review on their mode of action, treatment of abuse and intoxication (en anglès). Springer Science & Business Media, 2009, p. 147. ISBN 978-90-481-2448-0.
Mental and neurological public health a global perspective. 1a. Academic Press/Elsevier, 2010, p. 57. ISBN 978-0-12-381527-9.
Generation Ecstasy: Into the World of Techno and Rave Culture. Routledge, 1999, p. 81. ISBN 978-0-415-92373-6.
Addictions: a comprehensive guidebook. Segona. Oxford: Oxford University Press, 2013, p. 299. ISBN 978-0-19-975366-6.
Youth at Risk: A Prevention Resource for Counselors, Teachers, and Parents. John Wiley & Sons, 2014-11-21, p. 379. ISBN 978-1-119-02694-5.
Clinical Textbook of Addictive Disorders. Guilford Publications, 2016-05-12, p. 169. ISBN 978-1-4625-2169-2. «MDMA's addictive liability appears to be lower than that of other drugs of abuse...»
Principles of addiction medicine.. 4a. Filadèlfia: Wolters Kluwer/Lippincott Williams & Wilkins, 2009, p. 226. ISBN 978-0-7817-7477-2.
Clinical Textbook of Addictive Disorders. Guilford Publications, 2016-05-12, p. 171. ISBN 978-1-4625-2169-2.
Ecstasy : The MDMA Story. Expanded 2nd. Berkeley, CA: Ronin Publishing, 1994. ISBN 978-0-914171-68-3.
Drugs 2.0 : the web revolution that's changing how the world gets high (fitxer epub). Londres: Portobello, 2013. ISBN 978-1-84627-459-6.

cbc.ca (Global: 110^th place; Catalan: 319^th place)

«B.C. recorded 211 toxic drug deaths — almost 7 a day — in January, coroner reports». CBC.ca, 07-03-2023.

csp.org (Global: low place; Catalan: low place)

«The Agony and Ecstasy of God's path». Consell de Pràctiques Espirituals (CSP), 29-07-1995. Arxivat de l'original el 2013-04-24. [Consulta: 11 juny 2011].

doi.org (Global: 2^nd place; Catalan: 4^th place)

dx.doi.org

«There's something about Molly: The underresearched yet popular powder form of ecstasy in the United States». Substance Abuse, vol. 38, 1, 07-12-2016, p. 15–17. DOI: 10.1080/08897077.2016.1267070. PMC: 5578728. PMID: 27925866.
«3,4-metilendioximetanfetamina (MDMA): current perspectives». Substance Abuse and Rehabilitation, vol. 4, 2013, p. 83–99. DOI: 10.2147/SAR.S37258. PMC: 3931692. PMID: 24648791.
«MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study». Focus, vol. 21, 3, 7-2023, p. 315–328. DOI: 10.1176/appi.focus.23021011. PMC: 10316215. PMID: 37404971.
«MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults». Progress in Neuro-Psychopharmacology & Biological Psychiatry, vol. 64, 1-2016, p. 237–249. DOI: 10.1016/j.pnpbp.2015.03.011. PMID: 25818246.
«Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study». Psychopharmacology, vol. 235, 11, 11-2018, p. 3137–3148. DOI: 10.1007/s00213-018-5010-9. PMC: 6208958. PMID: 30196397.
«Pharmacological Effects of MDMA in Man». A: Pharmacology and Abuse of Cocaine, Amphetamines, Ecstasy and Related Designer Drugs. Springer Netherlands, 2009-07-28, p. 151–160. DOI 10.1007/978-90-481-2448-0_24. ISBN 978-90-481-2448-0.
«The origin of MDMA (ecstasy) revisited: the true story reconstructed from the original documents». Addiction, vol. 101, 9, 8-2006, p. 1241–1245. DOI: 10.1111/j.1360-0443.2006.01511.x. PMID: 16911722. «Although MDMA was, in fact, first synthesized at Merck in 1912, it was not tested pharmacologically because it was only an unimportant precursor in a new synthesis for haemostatic substances.»
«How MDMA's pharmacology and pharmacokinetics drive desired effects and harms». Journal of Clinical Pharmacology, vol. 54, 3. DOI: 10.1002/jcph.266. PMID: 24431106.
«Debunking the myth of 'Blue Mondays': No evidence of affect drop after taking clinical MDMA». Journal of Psychopharmacology, vol. 36, 3. DOI: 10.1177/02698811211055809. PMID: 34894842.
«Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms». Brain Research. Brain Research Reviews, vol. 42, 2. DOI: 10.1016/S0165-0173(03)00173-5. PMID: 12738056.
«Gender differences in the subjective effects of MDMA». Psychopharmacology, vol. 154, 2, 3-2001, p. 161–8. DOI: 10.1007/s002130000648. PMID: 11314678.
«Review article: amphetamines and related drugs of abuse». Emergency Medicine Australasia, vol. 20, 5, 10-2008, p. 391–402. DOI: 10.1111/j.1742-6723.2008.01114.x. PMID: 18973636.
«Decision-making in chronic ecstasy users: a systematic review». The European Journal of Neuroscience, vol. 45, 1, 1-2017, p. 34–44. DOI: 10.1111/ejn.13480. PMID: 27859780. «...the addictive potential of MDMA itself is relatively small.»
«Toxicity of amphetamines: an update». Archives of Toxicology, vol. 86, 8, 8-2012, p. 1167–231. DOI: 10.1007/s00204-012-0815-5. PMID: 22392347.
«Intimate insight: MDMA changes how people talk about significant others». Journal of Psychopharmacology, vol. 29, 6, 6-2015, p. 669–77. DOI: 10.1177/0269881115581962. PMC: 4698152. PMID: 25922420.
«Differential effects of MDMA and methylphenidate on social cognition». Journal of Psychopharmacology, vol. 28, 9, 9-2014, p. 847–56. DOI: 10.1177/0269881114542454. PMID: 25052243.
«MDMA alters emotional processing and facilitates positive social interaction». Psychopharmacology, vol. 231, 21, 10-2014, p. 4219–29. DOI: 10.1007/s00213-014-3570-x. PMC: 4194242. PMID: 24728603.
«The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals». Neuroscience and Biobehavioral Reviews, vol. 57, 10-2015, p. 433–46. DOI: 10.1016/j.neubiorev.2015.08.016. PMC: 4678620. PMID: 26408071.
«Duloxetine inhibits effects of MDMA ("ecstasy") in vitro and in humans in a randomized placebo-controlled laboratory study». PLOS ONE, vol. 7, 5, 04-05-2012, p. e36476. Bibcode: 2012PLoSO...736476H. DOI: 10.1371/journal.pone.0036476. PMC: 3344887. PMID: 22574166.
«Warning against co-administration of 3,4-methylenedioxymethamphetamine (MDMA) with methamphetamine from the perspective of pharmacokinetic and pharmacodynamic evaluations in rat brain». European Journal of Pharmaceutical Sciences, vol. 49, 1, 4-2013, p. 57–64. DOI: 10.1016/j.ejps.2013.01.014. PMID: 23395913.
«Ethanol increases the distribution of MDMA to the rat brain: possible implications in the ethanol-induced potentiation of the psychostimulant effects of MDMA». The International Journal of Neuropsychopharmacology, vol. 12, 6, 7-2009, p. 749–759. DOI: 10.1017/s1461145708009693. PMID: 19046482.
«Ecstasy: pharmacodynamic and pharmacokinetic interactions». Psychosomatics, vol. 45, 1, 01-03-2004, p. 84–87. DOI: 10.1176/appi.psy.45.1.84. PMID: 14709765.
«Making a medicine out of MDMA». The British Journal of Psychiatry, vol. 206, 1, 1-2015, p. 4–6. DOI: 10.1192/bjp.bp.114.152751. PMID: 25561485.
«Ecstacy: a review of MDMA and MDA». International Journal of Psychiatry in Medicine, vol. 16, 4, 1986, p. 359–72. DOI: 10.2190/dcrp-u22m-aumd-d84h. PMID: 2881902.
«Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials». Psychopharmacology, vol. 237, 8, 8-2020, p. 2485–2497. DOI: 10.1007/s00213-020-05548-2. PMC: 7351848. PMID: 32500209.
«Altered brain activity and functional connectivity after MDMA-assisted therapy for post-traumatic stress disorder». Frontiers in Psychiatry, vol. 13, 2023, p. 947622. DOI: 10.3389/fpsyt.2022.947622. ISSN: 1664-0640. PMC: 9879604. PMID: 36713926.
«New age seekers: MDMA use as an adjunct to spiritual pursuit». Journal of Psychoactive Drugs, vol. 23, 3, 1991, p. 261–70. DOI: 10.1080/02791072.1991.10471587. PMID: 1685513.
«Nephrotoxic effects of designer drugs: synthetic is not better!». Nature Reviews. Nephrology, vol. 10, 6, 6-2014, p. 314–24. DOI: 10.1038/nrneph.2014.44. PMID: 24662435.
«Recognising and managing acute hyponatraemia». Emergency Nurse, vol. 21, 9, 2-2014, p. 32–6; qüestionari 37. DOI: 10.7748/en2014.02.21.9.32.e1128. PMID: 24494770.
«Com la farmacologia i la farmacocinètica de l'MDMA condueixen als efectes desitjats i als danys». Journal of Clinical Pharmacology, vol. 54, 3, 3-2014, p. 245–52. DOI: 10.1002/jcph.266. PMID: 24431106.
«Consum de drogues, comportament de risc sexual i infeccions de transmissió sexual entre swingers: un estudi transversal als Països Baixos». Sexually Transmitted Infections, vol. 91, 1, 2-2015, p. 31–6. DOI: 10.1136/sextrans-2014-051626. PMID: 25342812. «Es coneix que algunes drogues recreatives (per exemple, MDMA o GHB) poden dificultar el potencial d'ejacular o mantenir una erecció.»
«Una sola exposició a cocaïna o èxtasi indueix dany al ADN al cervell i altres òrgans de ratolins». Biologia de l'Addicció, vol. 15, 1, 1-2010, p. 96–99. DOI: 10.1111/j.1369-1600.2009.00179.x. PMID: 19878142.
«Sleep loss and acute drug abuse can induce DNA damage in multiple organs of mice». Human & Experimental Toxicology, vol. 30, 9, 9-2011, p. 1275–1281. Bibcode: 2011HETox..30.1275A. DOI: 10.1177/0960327110388535. PMID: 21071548.
«DNA fragmentation and oxidative stress in the hippocampal formation: a bridge between 3,4-methylenedioxymethamphetamine (ecstasy) intake and long-lasting behavioral alterations». Behavioural Pharmacology, vol. 18, 5–6, 9-2007, p. 471–481. DOI: 10.1097/FBP.0b013e3282d518aa. PMID: 17762515.
«Functional Magnetic Resonance Imaging in Abstinent MDMA Users: A Review». Current Drug Abuse Reviews, vol. 8, 1, 2015, p. 15–25. DOI: 10.2174/1874473708666150303115833. PMID: 25731754.
«Neuroimaging in moderate MDMA use: A systematic review». Neuroscience and Biobehavioral Reviews, vol. 62, 3-2016, p. 21–34. DOI: 10.1016/j.neubiorev.2015.12.010. PMID: 26746590.
«Neurotoxicity of drugs of abuse--the case of methylenedioxyamphetamines (MDMA, ecstasy), and amphetamines». Dialogues in Clinical Neuroscience, vol. 11, 3, 2009, p. 305–17. DOI: 10.31887/DCNS.2009.11.3/egmayfrank. PMC: 3181923. PMID: 19877498.
«Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine». Life Sciences, vol. 97, 1, 2-2014, p. 37–44. DOI: 10.1016/j.lfs.2013.07.014. PMC: 3870191. PMID: 23892199. «In contrast, MDMA produces damage to serotonergic, but not dopaminergic axon terminals in the striatum, hippocampus, and prefrontal cortex. The damage associated with Meth and MDMA has been shown to persist for at least 2 years in rodents, non-human primates and humans»
«Are ecstasy induced serotonergic alterations overestimated for the majority of users?». Journal of Psychopharmacology, vol. 32, 7, 7-2018, p. 741–748. DOI: 10.1177/0269881118767646. PMID: 29733742. «Given the dose-response relationship between MDMA exposure and SERT reductions and the statistically non-significant SERT binding differences for users with use levels similar to the majority of real-life users, it can be speculated that SERT levels may not be significantly affected for most recreational ecstasy users.»
«Meta-analysis of molecular imaging of serotonin transporters in ecstasy/polydrug users». Neuroscience and Biobehavioral Reviews, vol. 63, 4-2016, p. 158–67. DOI: 10.1016/j.neubiorev.2016.02.003. PMID: 26855234.
«The potential dangers of using MDMA for psychotherapy». Journal of Psychoactive Drugs, vol. 46, 1, p. 37–43. DOI: 10.1080/02791072.2014.873690. PMID: 24830184.
«The harmful health effects of recreational ecstasy: a systematic review of observational evidence». Health Technology Assessment, 1-2009. DOI: 10.3310/hta13050. PMID: 19195429.
«Verbal Memory Impairment in Polydrug Ecstasy Users: A Clinical Perspective». PLOS ONE, vol. 11, 2, p. e0149438. Bibcode: 2016PLoSO..1149438K. DOI: 10.1371/journal.pone.0149438. PMC: 4764468. PMID: 26907605.
«Èxtasi (MDMA) i funció de la memòria: una actualització meta-analítica». Human Psychopharmacology, vol. 22, 6, 8-2007, p. 381–8. DOI: 10.1002/hup.857. PMID: 17621368.
«The effects of psychostimulant drugs on blood brain barrier function and neuroinflammation». Frontiers in Pharmacology, vol. 3, p. 121. DOI: 10.3389/fphar.2012.00121. PMC: 3386512. PMID: 22754527.
«Methylenedioxymethamphetamine ('Ecstasy')-induced immunosuppression: a cause for concern?». British Journal of Pharmacology, vol. 161, 1, p. 17–32. DOI: 10.1111/J.1476-5381.2010.00899.X. PMC: 2962814. PMID: 20718737.
«Safety Pharmacology assessment of drugs with biased 5-HT(2B) receptor agonism mediating cardiac valvulopathy». Journal of Pharmacological and Toxicological Methods, vol. 69, 2, 2014, p. 150–161. DOI: 10.1016/j.vascn.2013.12.004. PMID: 24361689.
«Cardiovascular Concern of 5-HT2B Receptor and Recent Vistas in the Development of Its Antagonists». Cardiovascular & Hematological Disorders Drug Targets, vol. 17, 2, 2017, p. 86–104. DOI: 10.2174/1871529X17666170703115111. PMID: 28676029.
«Ecstasy (MDMA) Alters Cardiac Gene Expression and DNA Methylation: Implications for Circadian Rhythm Dysfunction in the Heart». Ciències Tòxiques, vol. 148, 1, 11-2015, p. 183–191. DOI: 10.1093/toxsci/kfv170. PMC: 4731408. PMID: 26251327.
«Development of a rational scale to assess the harm of drugs of potential misuse». Lancet, vol. 369, 9566, 3-2007, p. 1047–1053. DOI: 10.1016/S0140-6736(07)60464-4. PMID: 17382831.
Nota de premsa: «Scientists want new drug rankings». Notícies de la BBC, 23-03-2007.
«DeltaFosB in the nucleus accumbens regulates food-reinforced instrumental behavior and motivation». The Journal of Neuroscience, vol. 26, 36, 9-2006, p. 9196–204. DOI: 10.1523/JNEUROSCI.1124-06.2006. PMC: 6674495. PMID: 16957076.
«Transcriptional and epigenetic mechanisms of addiction». Nature Reviews. Neuroscience, vol. 12, 11, 10-2011, p. 623–37. DOI: 10.1038/nrn3111. PMC: 3272277. PMID: 21989194.
«The Health Effect of Psychostimulants: A Literature Review». Pharmaceuticals, vol. 3, 7, 7-2010, p. 2333–2361. DOI: 10.3390/ph3072333. PMC: 4036656. PMID: 27713356. «It seems to present a smaller addiction potential than cocaine or methamphetamine.»
«The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine». Biological Chemistry, vol. 392, 1–2, 1-2011, p. 103–15. DOI: 10.1515/BC.2011.016. PMC: 4497800. PMID: 21194370.
«Methods for detecting long-term CNS dysfunction after prenatal exposure to neurotoxins». Drug and Chemical Toxicology, vol. 20, 4, 11-1997, p. 387–99. DOI: 10.3109/01480549709003895. PMID: 9433666.
«Toxicity of ecstasy (MDMA) towards embryonic stem cell-derived cardiac and neural cells». Toxicology in Vitro, vol. 24, 4, 6-2010, p. 1133–8. DOI: 10.1016/j.tiv.2010.03.005. PMID: 20230888.
«Neurobehavioral outcomes of infants exposed to MDMA (Ecstasy) and other recreational drugs during pregnancy». Neurotoxicology and Teratology, vol. 34, 3, 2012, p. 303–10. DOI: 10.1016/j.ntt.2012.02.001. PMC: 3367027. PMID: 22387807.
«Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans». British Journal of Pharmacology, vol. 166, 8, 8-2012, p. 2277–88. DOI: 10.1111/j.1476-5381.2012.01936.x. PMC: 3448893. PMID: 22404145.
«Caffeine provokes adverse interactions with 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') and related psychostimulants: mechanisms and mediators». British Journal of Pharmacology, vol. 167, 5, 11-2012, p. 946–59. DOI: 10.1111/j.1476-5381.2012.02065.x. PMC: 3492978. PMID: 22671762.
«Acute toxic effects of 'Ecstasy' (MDMA) and related compounds: overview of pathophysiology and clinical management». British Journal of Anaesthesia, vol. 96, 6, 6-2006, p. 678–85. DOI: 10.1093/bja/ael078. PMID: 16595612.
«Farmacologia humana de l'MDMA: farmacocinètica, metabolisme i disposició». Therapeutic Drug Monitoring, vol. 26, 2, 4-2004, p. 137–44. DOI: 10.1097/00007691-200404000-00009. PMID: 15228154. «Es coneix que algunes drogues recreatives (per exemple, l'MDMA o el GHB) poden dificultar la capacitat d'ejacular o mantenir una erecció.»
«Nephrotoxic effects of common and emerging drugs of abuse». Clinical Journal of the American Society of Nephrology, vol. 9, 11, 11-2014, p. 1996–2005. DOI: 10.2215/CJN.00360114. PMC: 4220747. PMID: 25035273.
«Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk». The Australian and New Zealand Journal of Psychiatry, vol. 41, 8, 8-2007, p. 649–55. DOI: 10.1080/00048670701449237. PMID: 17620161.
«MDMA interactions with pharmaceuticals and drugs of abuse». Expert Opin Drug Metab Toxicol, vol. 16, 5, 5-2020, p. 357–369. DOI: 10.1080/17425255.2020.1749262. PMID: 32228243.
«Death following ingestion of MDMA (ecstasy) and moclobemide». Addiction, vol. 98, 3, 3-2003, p. 365–8. DOI: 10.1046/j.1360-0443.2003.00292.x. PMID: 12603236.
«Serotonin and serotonin receptors in hallucinogen action». A: Manual de Neurobiologia Conductual de la Serotonina. 31, 2020, p. 843–863 (Handbook of Behavioral Neuroscience). DOI 10.1016/B978-0-444-64125-0.00043-8. ISBN 9780444641250.
«MDMA i activació de RhoA mitjançant TAAR1 en neurones serotoninèrgiques». The FASEB Journal, vol. 34, 1, 18-04-2020, p. 1. DOI: 10.1096/fasebj.2020.34.s1.05856.
«Les anfetamines senyalen a través dels receptors intracel·lulars TAAR1 acoblats a Gα₁₃ i Gα_S en dominis subcel·lulars discrets». Molecular Psychiatry, vol. 26, 4, 4-2021, p. 1208–1223. DOI: 10.1038/s41380-019-0469-2. PMC: 7038576. PMID: 31399635.
«Vesicular monoamine transporter 2 i la resposta aguda i a llarg termini a 3,4-(±)-metilendioximetanfetamina». Toxicological Sciences, vol. 143, 1, 1-2015, p. 209–219. DOI: 10.1093/toxsci/kfu222. PMC: 4274386. PMID: 25370842.
«(±)-MDMA i els seus enantiòmers: avantatges terapèutics potencials de R(-)-MDMA». Psychopharmacology, vol. 235, 2, 2-2018, p. 377–392. DOI: 10.1007/s00213-017-4812-5. PMID: 29248945.
«Quins neurotransmissors medien els efectes subjectius de l'MDMA en humans? Un resum dels estudis mecanístics». Human Psychopharmacology, vol. 16, 8, 12-2001, p. 589–598. DOI: 10.1002/hup.348. PMID: 12404538.
«Farmacocinètica no lineal de l'MDMA ('èxtasi') en humans». British Journal of Clinical Pharmacology, vol. 49, 2, 2-2000, p. 104–9. DOI: 10.1046/j.1365-2125.2000.00121.x. PMC: 2014905. PMID: 10671903.
«Farmacologia de l'MDMA en humans». Annals of the New York Academy of Sciences, vol. 914, 1, 9-2000, p. 225–37. Bibcode: 2000NYASA.914..225D. DOI: 10.1111/j.1749-6632.2000.tb05199.x. PMID: 11085324.
«Farmacocinètica plasmàtica de la 3,4-metilèndioximetanfetamina després d'administració oral controlada a adults joves». Therapeutic Drug Monitoring, vol. 30, 3, 6-2008, p. 320–32. DOI: 10.1097/FTD.0b013e3181684fa0. PMC: 2663855. PMID: 18520604.
«Determinació directa de glucurònid i sulfat de la 4-hidroxi-3-metoximetanfetamina, el principal metabòlit de l'MDMA, en orina humana». Journal of Chromatography B, vol. 857, 1, 9-2007, p. 123–9. DOI: 10.1016/j.jchromb.2007.07.003. PMID: 17643356.
«Anàlisi estereoespecífica i disposició enantiomèrica de la 3,4-metilèndioximetanfetamina (Èxtasi) en humans». Clinical Chemistry, vol. 45, 7, 7-1999, p. 1058–69. DOI: 10.1093/clinchem/45.7.1058. PMID: 10388483.
«Farmacocinètica no lineal de la (+/-)3,4-metilèndioximetanfetamina (MDMA, "Èxtasi") i els seus principals metabolits en micos esquirols a concentracions plasmàtiques d'MDMA que es desenvolupen després de dosis psicoactives típiques». The Journal of Pharmacology and Experimental Therapeutics, vol. 327, 1, 10-2008, p. 38–44. DOI: 10.1124/jpet.108.141366. PMID: 18591215.
«Impurity profiling of seized MDMA tablets by capillary gas chromatography». Analytical and Bioanalytical Chemistry, vol. 374, 2, 9-2002, p. 274–81. DOI: 10.1007/s00216-002-1477-6. PMID: 12324849.
«A study of the precursors, intermediates and reaction by-products in the synthesis of 3,4-methylenedioxymethylamphetamine and its application to forensic drug analysis». Forensic Science International, vol. 60, 3, 8-1993, p. 189–202. DOI: 10.1016/0379-0738(93)90238-6. PMID: 7901132.
«Disposition of MDMA and metabolites in human sweat following controlled MDMA administration». Química Clínica, vol. 55, 3, 3-2009, p. 454–62. DOI: 10.1373/clinchem.2008.117093. PMC: 2669283. PMID: 19168553.
«Relationship of the structure of mescaline and seven analogs to toxicity and behavior in five species of laboratory animals». Toxicology and Applied Pharmacology, vol. 25, 2, 6-1973, p. 299–309. DOI: 10.1016/S0041-008X(73)80016-X. PMID: 4197635.
«Rediscovering MDMA (ecstasy): the role of the American chemist Alexander T. Shulgin». Addiction, vol. 105, 8, 8-2010, p. 1355–61. DOI: 10.1111/j.1360-0443.2010.02948.x. PMID: 20653618.
«MDMA. Nonmedical use and intoxication». Journal of Psychoactive Drugs, vol. 18, 4, 10-1986, p. 349–54. DOI: 10.1080/02791072.1986.10472368. PMID: 2880950.
La primera mostra confiscada i identificada es va produir a Chicago el 1970: «Problems in Identification of Methylenedioxy and Methoxy Amphetamines». Journal of Criminal Law, Criminology, and Police Science, vol. 63, 2, p. 304–312. DOI: 10.2307/1142315. JSTOR: 1142315.
«An exploration of the history and controversies surrounding MDMA and MDA». Journal of Psychoactive Drugs, vol. 33, 3, 2001, p. 213–21. DOI: 10.1080/02791072.2001.10400568. PMID: 11718314.
Renfroe, CL «MDMA on the street: Analysis Anonymous». Journal of Psychoactive Drugs, 18, 4, 10-1986, p. 363–9. DOI: 10.1080/02791072.1986.10472371.
«Challenges with benchmarking of MDMA-assisted psychotherapy». . DOI: 10.1038/s41591-021-01525-0. PMID: 34635857.
«Equasy-- an overlooked addiction with implications for the current debate on drug harms». Journal of Psychopharmacology, vol. 23, 1, 1-2009, p. 3–5. DOI: 10.1177/0269881108099672. PMID: 19158127.
«Ecstasy use among US adolescents from 1999 to 2008». Drug and Alcohol Dependence, vol. 112, 1–2, 11-2010, p. 33–8. DOI: 10.1016/j.drugalcdep.2010.05.006. PMC: 2967577. PMID: 20570447.
European Monitoring Centre for Drugs Drug Addiction. «Ecstasy: high purity powder available». A: European Drug Report, 2014, p. 26. DOI 10.2810/32306. ISBN 978-92-9168-694-0. Arxivat 2014-09-07 a Wayback Machine.
«Monitoring of illicit pill distribution networks using an image collection exploration framework». Forensic Science International, vol. 223, 1–3, 11-2012, p. 298–305. DOI: 10.1016/j.forsciint.2012.10.004. PMID: 23107059. Arxivat 2021-08-28 a Wayback Machine.
«MDMA for the treatment of mood disorder: all talk no substance?». Therapeutic Advances in Psychopharmacology, vol. 5, 3, 6-2015, p. 179–88. DOI: 10.1177/2045125315583786. PMC: 4502590. PMID: 26199721.
«Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies». CNS Drugs, vol. 34, 9, 9-2020, p. 925–946. DOI: 10.1007/s40263-020-00748-y. PMC: 7447679. PMID: 32803732.
«Blinding and expectancy confounds in psychedelic randomized controlled trials». Expert Review of Clinical Pharmacology, vol. 14, 9, 9-2021, p. 1133–1152. DOI: 10.1080/17512433.2021.1933434. PMID: 34038314.
«Caution at psychiatry’s psychedelic frontier». Nature Medicine, vol. 27, 10, 10-2021, p. 1687–1688. DOI: 10.1038/s41591-021-01524-1. PMID: 34635858.
«Psychedelics Promote Structural and Functional Neural Plasticity» (en anglès). Cell Reports. DOI: 10.1016/j.celrep.2018.05.022. PMC: 6082376. PMID: 29898390.

drugabuse.gov (Global: low place; Catalan: low place)

«Drug facts: MDMA (Ecstasy/Molly)». National Institute on Drug Abuse, 01-02-2016. Arxivat de l'original el 2016-03-23. [Consulta: 30 març 2016].
«MDMA (Ecstasy/Molly)». National Institute on Drug Abuse. [Consulta: 14 juliol 2018].
«DrugFacts: MDMA (Ecstasy or Molly)». National Institute on Drug Abuse. Arxivat de l'original el 2014-12-03. [Consulta: 2 desembre 2014].

drugs.com (Global: 529^th place; Catalan: 330^th place)

«MDMA». Drugs.com. Drugsite Trust, 18-05-2014. Arxivat de l'original el 2016-03-23. [Consulta: 30 març 2016].

drugtext.org (Global: low place; Catalan: low place)

«10 years of ecstasy and other party drug use in Australia: What have we done and what is there left to do?». Drugtext.org. Arxivat de l'original el 2012-02-09.

erowid.org (Global: 3,273^rd place; Catalan: 4,924^th place)

«Relationship of the structure of mescaline and seven analogs to toxicity and behavior in five species of laboratory animals». Toxicology and Applied Pharmacology, vol. 25, 2, 6-1973, p. 299–309. DOI: 10.1016/S0041-008X(73)80016-X. PMID: 4197635.
La primera mostra confiscada i identificada es va produir a Chicago el 1970: «Problems in Identification of Methylenedioxy and Methoxy Amphetamines». Journal of Criminal Law, Criminology, and Police Science, vol. 63, 2, p. 304–312. DOI: 10.2307/1142315. JSTOR: 1142315.
«Drug Abuse Series: MDMA». Erowid. Projecte d'Informació i Monitorització de l'Abús de Drogues, 01-04-1987. [Consulta: 6 agost 2015].
«MDMA – FDA REPORT, 1985». Erowid.
«Erowid MDMA Vault : Imatges». [Consulta: 3 març 2016].

espacenet.com (Global: 950^th place; Catalan: 1,496^th place)

v3.espacenet.com

E. Merck a Darmstadt. «Patent alemanya 274350: German Patent 274350: Verfahren zur Darstellung von Alkyloxyaryl-, Dialkyloxyaryl- und Alkylendioxyarylaminopropanen bzw. deren am Stickstoff monoalkylierten Derivaten». Kaiserliches Patentamt, 16-05-1914. Arxivat de l'original el 2021-08-28. [Consulta: 12 abril 2009].
Firma E. Merck a Darmstadt. «Patent alemanya 279194: Verfahren zur Darstellung von Hydrastinin Derivaten». Kaiserliches Patentamt, 15-10-1914. Arxivat de l'original el 2021-08-28. [Consulta: 21 març 2024].

europa.eu (Global: 62^nd place; Catalan: 73^rd place)

emcdda.europa.eu

«Methylenedioxymethamphetamine (MDMA or 'Ecstasy')». EMCDDA. European Monitoring Centre for Drugs and Drug Addiction. [Consulta: 17 octubre 2014].
«Statistical Bulletin 2018 — prevalence of drug use». European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). [Consulta: 5 febrer 2019].
Centre de Vigilància de Drogues i Toxicomanies d'Europa. Annual report: the state of the drugs problem in Europe. Luxemburg: European Monitoring Centre for Drugs and Drug Addiction, 2008, p. 49. ISBN 978-92-9168-324-6. Arxivat 2013-04-25 a Wayback Machine.
European Monitoring Centre for Drugs Drug Addiction. «Ecstasy: high purity powder available». A: European Drug Report, 2014, p. 26. DOI 10.2810/32306. ISBN 978-92-9168-694-0. Arxivat 2014-09-07 a Wayback Machine.

forumclinic.org (Global: low place; Catalan: 4,001^st place)

Èxtasi i deteriorament cognitiu^{[Enllaç no actiu]} Hospital Clínic de Barcelona, 18 de febrer de 2008

fsijournal.org (Global: low place; Catalan: low place)

«Monitoring of illicit pill distribution networks using an image collection exploration framework». Forensic Science International, vol. 223, 1–3, 11-2012, p. 298–305. DOI: 10.1016/j.forsciint.2012.10.004. PMID: 23107059. Arxivat 2021-08-28 a Wayback Machine.

gov.bc.ca (Global: 1,686^th place; Catalan: 2,028^th place)

www2.gov.bc.ca

«Decriminalizing people who use drugs in B.C.». Government of BC. Government Communications and Public Engagement. [Consulta: 8 març 2023].

government.nl (Global: low place; Catalan: low place)

«Committee: the current system of the Opium Act does not have to be changed». government.nl, 24-06-2011. Arxivat de l'original el 2012-04-29. [Consulta: 29 agost 2012].

ingentaconnect.com (Global: 3,367^th place; Catalan: 1,485^th place)

«The origin of MDMA ("ecstasy")--separating the facts from the myth». Die Pharmazie, vol. 61, 11, 11-2006, p. 966–72. PMID: 17152992.

isomerdesign.com (Global: low place; Catalan: low place)

«Schedule I». Controlled Drugs and Substances Act. Isomer Design. Arxivat de l'original el 2013-11-10. [Consulta: 9 desembre 2013].
«Definitions and interpretations». Controlled Drugs and Substances Act. Isomer Design. Arxivat de l'original el 2013-11-10. [Consulta: 9 desembre 2013].

jstor.org (Global: 23^rd place; Catalan: 44^th place)

La primera mostra confiscada i identificada es va produir a Chicago el 1970: «Problems in Identification of Methylenedioxy and Methoxy Amphetamines». Journal of Criminal Law, Criminology, and Police Science, vol. 63, 2, p. 304–312. DOI: 10.2307/1142315. JSTOR: 1142315.

justia.com (Global: 673^rd place; Catalan: 2,304^th place)

law.justia.com

«Lester Grinspoon, M.D., Petitioner, v. Drug Enforcement Administration, Respondent, 828 F.2d 881 (1st Cir. 1987)». Justia Law. US Court of Appeals for the First Circuit.

justice.gov (Global: 884^th place; Catalan: 1,487^th place)

«Early Warning - MDMA and MDA Producers Using Ocotea Cymbarum as a Precursor». DEA Microgram Newsletter. Drug Enforcement Agency, U.S. Department of Justice, vol. 38, 11, 11-11-2005, p. 166. Arxivat 2012-10-18 a Wayback Machine.

kwtx.com (Global: low place; Catalan: low place)

«Groesbeck: Students caught with deceptively shaped Ecstasy pills». KWTX, 31-10-2019.

latimes.com (Global: 32^nd place; Catalan: 91^st place)

latimes.com

«Exploring therapeutic effects of MDMA on post-traumatic stress». Los Angeles Times, 15-03-2014.

articles.latimes.com

«U.S. to Ban Use of Drug MDMA : Street Abuse Cited; Used by Psychiatrists». , 31-05-1985.

maps.org (Global: low place; Catalan: low place)

«MDMA. Nonmedical use and intoxication». Journal of Psychoactive Drugs, vol. 18, 4, 10-1986, p. 349–54. DOI: 10.1080/02791072.1986.10472368. PMID: 2880950.
«Schedules of Controlled Substances Proposed Placement of 3,4-Methylenedioxymethamphetamine in Schedule I». Federal Register, 27-07-1984.
«Getting High on 'Ecstasy'». Newsweek Magazine, 15-04-1985, p. 96.
«Bibliografia d'Estudis de Recerca Psicodèlics.». Associació Multidisciplinària d'Estudis Psicodèlics (MAPS). Arxivat de l'original el 2013-12-03.

medscape.com (Global: 1,078^th place; Catalan: 758^th place)

emedicine.medscape.com

«Toxicitat de l'MDMA: Antecedents, Fisiopatologia, Epidemiologia». Medscape, 25-03-2015. [Consulta: 14 maig 2016].

nbcnews.com (Global: 156^th place; Catalan: 447^th place)

«What Is Molly and Why Is It Dangerous?». NBCNews.com, 23-02-2015. [Consulta: 23 febrer 2015].

newspaperarchive.com (Global: 1,148^th place; Catalan: 4,707^th place)

«Ecstasy has its pros and cons». Harper's Bazaar, 23-11-1985, p. 6.

nih.gov (Global: 5^th place; Catalan: 7^th place)

ncbi.nlm.nih.gov

«There's something about Molly: The underresearched yet popular powder form of ecstasy in the United States». Substance Abuse, vol. 38, 1, 07-12-2016, p. 15–17. DOI: 10.1080/08897077.2016.1267070. PMC: 5578728. PMID: 27925866.
«3,4-metilendioximetanfetamina (MDMA): current perspectives». Substance Abuse and Rehabilitation, vol. 4, 2013, p. 83–99. DOI: 10.2147/SAR.S37258. PMC: 3931692. PMID: 24648791.
«MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study». Focus, vol. 21, 3, 7-2023, p. 315–328. DOI: 10.1176/appi.focus.23021011. PMC: 10316215. PMID: 37404971.
«MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults». Progress in Neuro-Psychopharmacology & Biological Psychiatry, vol. 64, 1-2016, p. 237–249. DOI: 10.1016/j.pnpbp.2015.03.011. PMID: 25818246.
«Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study». Psychopharmacology, vol. 235, 11, 11-2018, p. 3137–3148. DOI: 10.1007/s00213-018-5010-9. PMC: 6208958. PMID: 30196397.
«The origin of MDMA (ecstasy) revisited: the true story reconstructed from the original documents». Addiction, vol. 101, 9, 8-2006, p. 1241–1245. DOI: 10.1111/j.1360-0443.2006.01511.x. PMID: 16911722. «Although MDMA was, in fact, first synthesized at Merck in 1912, it was not tested pharmacologically because it was only an unimportant precursor in a new synthesis for haemostatic substances.»
«How MDMA's pharmacology and pharmacokinetics drive desired effects and harms». Journal of Clinical Pharmacology, vol. 54, 3. DOI: 10.1002/jcph.266. PMID: 24431106.
«Debunking the myth of 'Blue Mondays': No evidence of affect drop after taking clinical MDMA». Journal of Psychopharmacology, vol. 36, 3. DOI: 10.1177/02698811211055809. PMID: 34894842.
«Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms». Brain Research. Brain Research Reviews, vol. 42, 2. DOI: 10.1016/S0165-0173(03)00173-5. PMID: 12738056.
«Gender differences in the subjective effects of MDMA». Psychopharmacology, vol. 154, 2, 3-2001, p. 161–8. DOI: 10.1007/s002130000648. PMID: 11314678.
«Review article: amphetamines and related drugs of abuse». Emergency Medicine Australasia, vol. 20, 5, 10-2008, p. 391–402. DOI: 10.1111/j.1742-6723.2008.01114.x. PMID: 18973636.
«Decision-making in chronic ecstasy users: a systematic review». The European Journal of Neuroscience, vol. 45, 1, 1-2017, p. 34–44. DOI: 10.1111/ejn.13480. PMID: 27859780. «...the addictive potential of MDMA itself is relatively small.»
«Toxicity of amphetamines: an update». Archives of Toxicology, vol. 86, 8, 8-2012, p. 1167–231. DOI: 10.1007/s00204-012-0815-5. PMID: 22392347.
«Intimate insight: MDMA changes how people talk about significant others». Journal of Psychopharmacology, vol. 29, 6, 6-2015, p. 669–77. DOI: 10.1177/0269881115581962. PMC: 4698152. PMID: 25922420.
«Differential effects of MDMA and methylphenidate on social cognition». Journal of Psychopharmacology, vol. 28, 9, 9-2014, p. 847–56. DOI: 10.1177/0269881114542454. PMID: 25052243.
«MDMA alters emotional processing and facilitates positive social interaction». Psychopharmacology, vol. 231, 21, 10-2014, p. 4219–29. DOI: 10.1007/s00213-014-3570-x. PMC: 4194242. PMID: 24728603.
«The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals». Neuroscience and Biobehavioral Reviews, vol. 57, 10-2015, p. 433–46. DOI: 10.1016/j.neubiorev.2015.08.016. PMC: 4678620. PMID: 26408071.
«Duloxetine inhibits effects of MDMA ("ecstasy") in vitro and in humans in a randomized placebo-controlled laboratory study». PLOS ONE, vol. 7, 5, 04-05-2012, p. e36476. Bibcode: 2012PLoSO...736476H. DOI: 10.1371/journal.pone.0036476. PMC: 3344887. PMID: 22574166.
«Warning against co-administration of 3,4-methylenedioxymethamphetamine (MDMA) with methamphetamine from the perspective of pharmacokinetic and pharmacodynamic evaluations in rat brain». European Journal of Pharmaceutical Sciences, vol. 49, 1, 4-2013, p. 57–64. DOI: 10.1016/j.ejps.2013.01.014. PMID: 23395913.
«Ethanol increases the distribution of MDMA to the rat brain: possible implications in the ethanol-induced potentiation of the psychostimulant effects of MDMA». The International Journal of Neuropsychopharmacology, vol. 12, 6, 7-2009, p. 749–759. DOI: 10.1017/s1461145708009693. PMID: 19046482.
«Ecstasy: pharmacodynamic and pharmacokinetic interactions». Psychosomatics, vol. 45, 1, 01-03-2004, p. 84–87. DOI: 10.1176/appi.psy.45.1.84. PMID: 14709765.
«Clinically Relevant Drug-Drug Interactions in Primary Care». American Family Physician, vol. 99, 9, 5-2019, p. 558–564. PMID: 31038898.
«Making a medicine out of MDMA». The British Journal of Psychiatry, vol. 206, 1, 1-2015, p. 4–6. DOI: 10.1192/bjp.bp.114.152751. PMID: 25561485.
«Behavioral and Stereological Analysis of the Effects of Intermittent Feeding Diet on the Orally Administrated MDMA ("ecstasy") in Mice». Innovations in Clinical Neuroscience, vol. 14, 1–2, 01-02-2017, p. 40–52. PMC: 5373794. PMID: 28386520. «MDMA is listed as a Schedule 1 drug by the United States Drug Enforcement Agency, meaning that currently there are no accepted medical uses for MDMA in the United States, there is a lack of accepted safety for use under medical supervision, and there is a high potential for abuse»
«Ecstacy: a review of MDMA and MDA». International Journal of Psychiatry in Medicine, vol. 16, 4, 1986, p. 359–72. DOI: 10.2190/dcrp-u22m-aumd-d84h. PMID: 2881902.
«Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials». Psychopharmacology, vol. 237, 8, 8-2020, p. 2485–2497. DOI: 10.1007/s00213-020-05548-2. PMC: 7351848. PMID: 32500209.
«Altered brain activity and functional connectivity after MDMA-assisted therapy for post-traumatic stress disorder». Frontiers in Psychiatry, vol. 13, 2023, p. 947622. DOI: 10.3389/fpsyt.2022.947622. ISSN: 1664-0640. PMC: 9879604. PMID: 36713926.
«New age seekers: MDMA use as an adjunct to spiritual pursuit». Journal of Psychoactive Drugs, vol. 23, 3, 1991, p. 261–70. DOI: 10.1080/02791072.1991.10471587. PMID: 1685513.
«Nephrotoxic effects of designer drugs: synthetic is not better!». Nature Reviews. Nephrology, vol. 10, 6, 6-2014, p. 314–24. DOI: 10.1038/nrneph.2014.44. PMID: 24662435.
«Recognising and managing acute hyponatraemia». Emergency Nurse, vol. 21, 9, 2-2014, p. 32–6; qüestionari 37. DOI: 10.7748/en2014.02.21.9.32.e1128. PMID: 24494770.
«Com la farmacologia i la farmacocinètica de l'MDMA condueixen als efectes desitjats i als danys». Journal of Clinical Pharmacology, vol. 54, 3, 3-2014, p. 245–52. DOI: 10.1002/jcph.266. PMID: 24431106.
«Consum de drogues, comportament de risc sexual i infeccions de transmissió sexual entre swingers: un estudi transversal als Països Baixos». Sexually Transmitted Infections, vol. 91, 1, 2-2015, p. 31–6. DOI: 10.1136/sextrans-2014-051626. PMID: 25342812. «Es coneix que algunes drogues recreatives (per exemple, MDMA o GHB) poden dificultar el potencial d'ejacular o mantenir una erecció.»
«Una sola exposició a cocaïna o èxtasi indueix dany al ADN al cervell i altres òrgans de ratolins». Biologia de l'Addicció, vol. 15, 1, 1-2010, p. 96–99. DOI: 10.1111/j.1369-1600.2009.00179.x. PMID: 19878142.
«Sleep loss and acute drug abuse can induce DNA damage in multiple organs of mice». Human & Experimental Toxicology, vol. 30, 9, 9-2011, p. 1275–1281. Bibcode: 2011HETox..30.1275A. DOI: 10.1177/0960327110388535. PMID: 21071548.
«DNA fragmentation and oxidative stress in the hippocampal formation: a bridge between 3,4-methylenedioxymethamphetamine (ecstasy) intake and long-lasting behavioral alterations». Behavioural Pharmacology, vol. 18, 5–6, 9-2007, p. 471–481. DOI: 10.1097/FBP.0b013e3282d518aa. PMID: 17762515.
«Functional Magnetic Resonance Imaging in Abstinent MDMA Users: A Review». Current Drug Abuse Reviews, vol. 8, 1, 2015, p. 15–25. DOI: 10.2174/1874473708666150303115833. PMID: 25731754.
«Neuroimaging in moderate MDMA use: A systematic review». Neuroscience and Biobehavioral Reviews, vol. 62, 3-2016, p. 21–34. DOI: 10.1016/j.neubiorev.2015.12.010. PMID: 26746590.
«Neurotoxicity of drugs of abuse--the case of methylenedioxyamphetamines (MDMA, ecstasy), and amphetamines». Dialogues in Clinical Neuroscience, vol. 11, 3, 2009, p. 305–17. DOI: 10.31887/DCNS.2009.11.3/egmayfrank. PMC: 3181923. PMID: 19877498.
«Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine». Life Sciences, vol. 97, 1, 2-2014, p. 37–44. DOI: 10.1016/j.lfs.2013.07.014. PMC: 3870191. PMID: 23892199. «In contrast, MDMA produces damage to serotonergic, but not dopaminergic axon terminals in the striatum, hippocampus, and prefrontal cortex. The damage associated with Meth and MDMA has been shown to persist for at least 2 years in rodents, non-human primates and humans»
«Are ecstasy induced serotonergic alterations overestimated for the majority of users?». Journal of Psychopharmacology, vol. 32, 7, 7-2018, p. 741–748. DOI: 10.1177/0269881118767646. PMID: 29733742. «Given the dose-response relationship between MDMA exposure and SERT reductions and the statistically non-significant SERT binding differences for users with use levels similar to the majority of real-life users, it can be speculated that SERT levels may not be significantly affected for most recreational ecstasy users.»
«Meta-analysis of molecular imaging of serotonin transporters in ecstasy/polydrug users». Neuroscience and Biobehavioral Reviews, vol. 63, 4-2016, p. 158–67. DOI: 10.1016/j.neubiorev.2016.02.003. PMID: 26855234.
«The potential dangers of using MDMA for psychotherapy». Journal of Psychoactive Drugs, vol. 46, 1, p. 37–43. DOI: 10.1080/02791072.2014.873690. PMID: 24830184.
«The harmful health effects of recreational ecstasy: a systematic review of observational evidence». Health Technology Assessment, 1-2009. DOI: 10.3310/hta13050. PMID: 19195429.
«Verbal Memory Impairment in Polydrug Ecstasy Users: A Clinical Perspective». PLOS ONE, vol. 11, 2, p. e0149438. Bibcode: 2016PLoSO..1149438K. DOI: 10.1371/journal.pone.0149438. PMC: 4764468. PMID: 26907605.
«Èxtasi (MDMA) i funció de la memòria: una actualització meta-analítica». Human Psychopharmacology, vol. 22, 6, 8-2007, p. 381–8. DOI: 10.1002/hup.857. PMID: 17621368.
«The effects of psychostimulant drugs on blood brain barrier function and neuroinflammation». Frontiers in Pharmacology, vol. 3, p. 121. DOI: 10.3389/fphar.2012.00121. PMC: 3386512. PMID: 22754527.
«Methylenedioxymethamphetamine ('Ecstasy')-induced immunosuppression: a cause for concern?». British Journal of Pharmacology, vol. 161, 1, p. 17–32. DOI: 10.1111/J.1476-5381.2010.00899.X. PMC: 2962814. PMID: 20718737.
«Safety Pharmacology assessment of drugs with biased 5-HT(2B) receptor agonism mediating cardiac valvulopathy». Journal of Pharmacological and Toxicological Methods, vol. 69, 2, 2014, p. 150–161. DOI: 10.1016/j.vascn.2013.12.004. PMID: 24361689.
«Cardiovascular Concern of 5-HT2B Receptor and Recent Vistas in the Development of Its Antagonists». Cardiovascular & Hematological Disorders Drug Targets, vol. 17, 2, 2017, p. 86–104. DOI: 10.2174/1871529X17666170703115111. PMID: 28676029.
«Ecstasy (MDMA) Alters Cardiac Gene Expression and DNA Methylation: Implications for Circadian Rhythm Dysfunction in the Heart». Ciències Tòxiques, vol. 148, 1, 11-2015, p. 183–191. DOI: 10.1093/toxsci/kfv170. PMC: 4731408. PMID: 26251327.
«Development of a rational scale to assess the harm of drugs of potential misuse». Lancet, vol. 369, 9566, 3-2007, p. 1047–1053. DOI: 10.1016/S0140-6736(07)60464-4. PMID: 17382831.
Nota de premsa: «Scientists want new drug rankings». Notícies de la BBC, 23-03-2007.
«DeltaFosB in the nucleus accumbens regulates food-reinforced instrumental behavior and motivation». The Journal of Neuroscience, vol. 26, 36, 9-2006, p. 9196–204. DOI: 10.1523/JNEUROSCI.1124-06.2006. PMC: 6674495. PMID: 16957076.
«Transcriptional and epigenetic mechanisms of addiction». Nature Reviews. Neuroscience, vol. 12, 11, 10-2011, p. 623–37. DOI: 10.1038/nrn3111. PMC: 3272277. PMID: 21989194.
«The Health Effect of Psychostimulants: A Literature Review». Pharmaceuticals, vol. 3, 7, 7-2010, p. 2333–2361. DOI: 10.3390/ph3072333. PMC: 4036656. PMID: 27713356. «It seems to present a smaller addiction potential than cocaine or methamphetamine.»
«The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine». Biological Chemistry, vol. 392, 1–2, 1-2011, p. 103–15. DOI: 10.1515/BC.2011.016. PMC: 4497800. PMID: 21194370.
«Methods for detecting long-term CNS dysfunction after prenatal exposure to neurotoxins». Drug and Chemical Toxicology, vol. 20, 4, 11-1997, p. 387–99. DOI: 10.3109/01480549709003895. PMID: 9433666.
«Toxicity of ecstasy (MDMA) towards embryonic stem cell-derived cardiac and neural cells». Toxicology in Vitro, vol. 24, 4, 6-2010, p. 1133–8. DOI: 10.1016/j.tiv.2010.03.005. PMID: 20230888.
«Neurobehavioral outcomes of infants exposed to MDMA (Ecstasy) and other recreational drugs during pregnancy». Neurotoxicology and Teratology, vol. 34, 3, 2012, p. 303–10. DOI: 10.1016/j.ntt.2012.02.001. PMC: 3367027. PMID: 22387807.
«Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans». British Journal of Pharmacology, vol. 166, 8, 8-2012, p. 2277–88. DOI: 10.1111/j.1476-5381.2012.01936.x. PMC: 3448893. PMID: 22404145.
«Caffeine provokes adverse interactions with 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') and related psychostimulants: mechanisms and mediators». British Journal of Pharmacology, vol. 167, 5, 11-2012, p. 946–59. DOI: 10.1111/j.1476-5381.2012.02065.x. PMC: 3492978. PMID: 22671762.
«Acute toxic effects of 'Ecstasy' (MDMA) and related compounds: overview of pathophysiology and clinical management». British Journal of Anaesthesia, vol. 96, 6, 6-2006, p. 678–85. DOI: 10.1093/bja/ael078. PMID: 16595612.
«Farmacologia humana de l'MDMA: farmacocinètica, metabolisme i disposició». Therapeutic Drug Monitoring, vol. 26, 2, 4-2004, p. 137–44. DOI: 10.1097/00007691-200404000-00009. PMID: 15228154. «Es coneix que algunes drogues recreatives (per exemple, l'MDMA o el GHB) poden dificultar la capacitat d'ejacular o mantenir una erecció.»
«Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition». Therapeutic Drug Monitoring, vol. 26, 2, 4-2004, p. 137–44. PMID: 15228154.
«3,4-methylenedioxyamfetamine (ecstasy) use reduces cognition». British Journal of Nursing, vol. 19, 2, 2010, p. 94–100. PMID: 20235382.
«Nephrotoxic effects of common and emerging drugs of abuse». Clinical Journal of the American Society of Nephrology, vol. 9, 11, 11-2014, p. 1996–2005. DOI: 10.2215/CJN.00360114. PMC: 4220747. PMID: 25035273.
«Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk». The Australian and New Zealand Journal of Psychiatry, vol. 41, 8, 8-2007, p. 649–55. DOI: 10.1080/00048670701449237. PMID: 17620161.
«MDMA interactions with pharmaceuticals and drugs of abuse». Expert Opin Drug Metab Toxicol, vol. 16, 5, 5-2020, p. 357–369. DOI: 10.1080/17425255.2020.1749262. PMID: 32228243.
«Death following ingestion of MDMA (ecstasy) and moclobemide». Addiction, vol. 98, 3, 3-2003, p. 365–8. DOI: 10.1046/j.1360-0443.2003.00292.x. PMID: 12603236.
«Les anfetamines senyalen a través dels receptors intracel·lulars TAAR1 acoblats a Gα₁₃ i Gα_S en dominis subcel·lulars discrets». Molecular Psychiatry, vol. 26, 4, 4-2021, p. 1208–1223. DOI: 10.1038/s41380-019-0469-2. PMC: 7038576. PMID: 31399635.
«Vesicular monoamine transporter 2 i la resposta aguda i a llarg termini a 3,4-(±)-metilendioximetanfetamina». Toxicological Sciences, vol. 143, 1, 1-2015, p. 209–219. DOI: 10.1093/toxsci/kfu222. PMC: 4274386. PMID: 25370842.
«(±)-MDMA i els seus enantiòmers: avantatges terapèutics potencials de R(-)-MDMA». Psychopharmacology, vol. 235, 2, 2-2018, p. 377–392. DOI: 10.1007/s00213-017-4812-5. PMID: 29248945.
«Quins neurotransmissors medien els efectes subjectius de l'MDMA en humans? Un resum dels estudis mecanístics». Human Psychopharmacology, vol. 16, 8, 12-2001, p. 589–598. DOI: 10.1002/hup.348. PMID: 12404538.
«Efectes cardiovasculars i neuroendocrins i farmacocinètica de la 3,4-metilendioximetanfetamina en humans». The Journal of Pharmacology and Experimental Therapeutics, vol. 290, 1, 7-1999, p. 136–45. PMID: 10381769.
«Farmacocinètica no lineal de l'MDMA ('èxtasi') en humans». British Journal of Clinical Pharmacology, vol. 49, 2, 2-2000, p. 104–9. DOI: 10.1046/j.1365-2125.2000.00121.x. PMC: 2014905. PMID: 10671903.
«Farmacologia de l'MDMA en humans». Annals of the New York Academy of Sciences, vol. 914, 1, 9-2000, p. 225–37. Bibcode: 2000NYASA.914..225D. DOI: 10.1111/j.1749-6632.2000.tb05199.x. PMID: 11085324.
«Farmacocinètica plasmàtica de la 3,4-metilèndioximetanfetamina després d'administració oral controlada a adults joves». Therapeutic Drug Monitoring, vol. 30, 3, 6-2008, p. 320–32. DOI: 10.1097/FTD.0b013e3181684fa0. PMC: 2663855. PMID: 18520604.
«Determinació directa de glucurònid i sulfat de la 4-hidroxi-3-metoximetanfetamina, el principal metabòlit de l'MDMA, en orina humana». Journal of Chromatography B, vol. 857, 1, 9-2007, p. 123–9. DOI: 10.1016/j.jchromb.2007.07.003. PMID: 17643356.
«Anàlisi estereoespecífica i disposició enantiomèrica de la 3,4-metilèndioximetanfetamina (Èxtasi) en humans». Clinical Chemistry, vol. 45, 7, 7-1999, p. 1058–69. DOI: 10.1093/clinchem/45.7.1058. PMID: 10388483.
«Farmacocinètica no lineal de la (+/-)3,4-metilèndioximetanfetamina (MDMA, "Èxtasi") i els seus principals metabolits en micos esquirols a concentracions plasmàtiques d'MDMA que es desenvolupen després de dosis psicoactives típiques». The Journal of Pharmacology and Experimental Therapeutics, vol. 327, 1, 10-2008, p. 38–44. DOI: 10.1124/jpet.108.141366. PMID: 18591215.
«Impurity profiling of seized MDMA tablets by capillary gas chromatography». Analytical and Bioanalytical Chemistry, vol. 374, 2, 9-2002, p. 274–81. DOI: 10.1007/s00216-002-1477-6. PMID: 12324849.
«A study of the precursors, intermediates and reaction by-products in the synthesis of 3,4-methylenedioxymethylamphetamine and its application to forensic drug analysis». Forensic Science International, vol. 60, 3, 8-1993, p. 189–202. DOI: 10.1016/0379-0738(93)90238-6. PMID: 7901132.
«Disposition of MDMA and metabolites in human sweat following controlled MDMA administration». Química Clínica, vol. 55, 3, 3-2009, p. 454–62. DOI: 10.1373/clinchem.2008.117093. PMC: 2669283. PMID: 19168553.
«The origin of MDMA ("ecstasy")--separating the facts from the myth». Die Pharmazie, vol. 61, 11, 11-2006, p. 966–72. PMID: 17152992.
«Relationship of the structure of mescaline and seven analogs to toxicity and behavior in five species of laboratory animals». Toxicology and Applied Pharmacology, vol. 25, 2, 6-1973, p. 299–309. DOI: 10.1016/S0041-008X(73)80016-X. PMID: 4197635.
«Rediscovering MDMA (ecstasy): the role of the American chemist Alexander T. Shulgin». Addiction, vol. 105, 8, 8-2010, p. 1355–61. DOI: 10.1111/j.1360-0443.2010.02948.x. PMID: 20653618.
«MDMA. Nonmedical use and intoxication». Journal of Psychoactive Drugs, vol. 18, 4, 10-1986, p. 349–54. DOI: 10.1080/02791072.1986.10472368. PMID: 2880950.
«An exploration of the history and controversies surrounding MDMA and MDA». Journal of Psychoactive Drugs, vol. 33, 3, 2001, p. 213–21. DOI: 10.1080/02791072.2001.10400568. PMID: 11718314.
«Challenges with benchmarking of MDMA-assisted psychotherapy». . DOI: 10.1038/s41591-021-01525-0. PMID: 34635857.
«Equasy-- an overlooked addiction with implications for the current debate on drug harms». Journal of Psychopharmacology, vol. 23, 1, 1-2009, p. 3–5. DOI: 10.1177/0269881108099672. PMID: 19158127.
«Ecstasy use among US adolescents from 1999 to 2008». Drug and Alcohol Dependence, vol. 112, 1–2, 11-2010, p. 33–8. DOI: 10.1016/j.drugalcdep.2010.05.006. PMC: 2967577. PMID: 20570447.
«Monitoring of illicit pill distribution networks using an image collection exploration framework». Forensic Science International, vol. 223, 1–3, 11-2012, p. 298–305. DOI: 10.1016/j.forsciint.2012.10.004. PMID: 23107059. Arxivat 2021-08-28 a Wayback Machine.
«MDMA for the treatment of mood disorder: all talk no substance?». Therapeutic Advances in Psychopharmacology, vol. 5, 3, 6-2015, p. 179–88. DOI: 10.1177/2045125315583786. PMC: 4502590. PMID: 26199721.
«Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies». CNS Drugs, vol. 34, 9, 9-2020, p. 925–946. DOI: 10.1007/s40263-020-00748-y. PMC: 7447679. PMID: 32803732.
«Blinding and expectancy confounds in psychedelic randomized controlled trials». Expert Review of Clinical Pharmacology, vol. 14, 9, 9-2021, p. 1133–1152. DOI: 10.1080/17512433.2021.1933434. PMID: 34038314.
«Caution at psychiatry’s psychedelic frontier». Nature Medicine, vol. 27, 10, 10-2021, p. 1687–1688. DOI: 10.1038/s41591-021-01524-1. PMID: 34635858.
«Psychedelics Promote Structural and Functional Neural Plasticity» (en anglès). Cell Reports. DOI: 10.1016/j.celrep.2018.05.022. PMC: 6082376. PMID: 29898390.

toxnet.nlm.nih.gov

«3,4-Methylenedioxymethamphetamine». Hazardous Substances Data Bank. National Library of Medicine, 28-08-2008. [Consulta: 22 agost 2014].

nintendoenthusiast.com (Global: low place; Catalan: low place)

«Man arrested for possession of ecstasy tablets shaped like Wario». Nintendo Enthusiast, 20-06-2019. Arxivat de l'original el 2021-06-24. [Consulta: 17 juny 2021].

nytimes.com (Global: 7^th place; Catalan: 14^th place)

nytimes.com

«Ecstasy as a Remedy for PTSD? You Probably Have Some Questions» (en anglès). , 01-05-2018.
«Psychedelic Drug Called Ecstasy Gains Popularity in Manhattan Nightclubs». The New York Times, 11-12-1988.
«Dr. Ecstasy». The New York Times Magazine, 30-01-2005.
«U.S. will ban 'ecstasy,' a hallucinogenic drug». The Associated Press, 01-06-1985.
«Alexander Shulgin, Psychedelia Researcher, Dies at 88». The New York Times, 07-06-2014.
«Molly: Pure, but Not So Simple». The New York Times, 21-06-2013.

artsbeat.blogs.nytimes.com

«Overdoses of 'Molly' Led to Electric Zoo Deaths». , 12-09-2013.

playboy.com (Global: 4,392^nd place; Catalan: 4,515^th place)

«Molly Isn't Who You Think She Is: A Deeper Look at MDMA». Playboy. 2013-10-20. Arxivat de l'original el 2015-07-27.

racgp.org.au (Global: low place; Catalan: low place)

www1.racgp.org.au

«MDMA and psilocybin: What GPs need to know». RACGP. [Consulta: 13 juny 2023].

researchgate.net (Global: 96^th place; Catalan: 89^th place)

«The potential dangers of using MDMA for psychotherapy». Journal of Psychoactive Drugs, vol. 46, 1, p. 37–43. DOI: 10.1080/02791072.2014.873690. PMID: 24830184.

rijksoverheid.nl (Global: 3,767^th place; Catalan: 8,710^th place)

«Rapport Drugs in Lijsten». Rijksoverheid.nl, 27-06-2011. Arxivat de l'original el 2012-03-06. [Consulta: 29 agost 2012].

science.org (Global: 1,007^th place; Catalan: 895^th place)

«All clear for the decisive trial of ecstasy in PTSD patients» (en anglès). Science (magazine), 26-08-2017. [Consulta: 3 abril 2021].

scientopia.org (Global: low place; Catalan: low place)

«Mephedrone (4-Methylmethcathinone) appearing in "Ecstasy" in the Netherlands». , 19-09-2010. Arxivat 2012-11-05 a Wayback Machine.

shulginresearch.org (Global: low place; Catalan: low place)

«Alexander 'Sasha' Shulgin». Alexander Shulgin Research Institute. Arxivat de l'original el 2014-12-20. [Consulta: 8 gener 2015].

slp.wa.gov.au (Global: low place; Catalan: low place)

«Misuse of Drugs Act 1981». The Government of Western Australia, 23-10-1981.

statutelaw.gov.uk (Global: low place; Catalan: low place)

«Misuse of Drugs Act 1971». Statutelaw.gov.uk, 05-01-1998. [Consulta: 11 juny 2011].

telegraph.co.uk (Global: 40^th place; Catalan: 86^th place)

«Ecstasy 'no more dangerous than horse riding'». , 07-02-2009.

thedea.org (Global: low place; Catalan: low place)

«The origin of MDMA (ecstasy) revisited: the true story reconstructed from the original documents». Addiction, vol. 101, 9, 8-2006, p. 1241–1245. DOI: 10.1111/j.1360-0443.2006.01511.x. PMID: 16911722. «Although MDMA was, in fact, first synthesized at Merck in 1912, it was not tested pharmacologically because it was only an unimportant precursor in a new synthesis for haemostatic substances.»

thedocumentarygroup.com (Global: low place; Catalan: low place)

«Ecstasy rising». Primetime Thursday. ABC News, 01-04-2004. Arxivat 2015-05-27 a Wayback Machine.

theguardian.com (Global: 16^th place; Catalan: 29^th place)

«Why Professor David Nutt was shown the door». [Londres], 02-11-2009.
«World's first trials of MDMA to treat alcohol addiction set to begin». The Guardian, 30-06-2017.

ung.no (Global: low place; Catalan: low place)

«Hva er tryggest av molly og ecstasy?» (en noruec). Ung.no. Norwegian Directorate for Children, Youth and Family Affairs. Arxivat de l'original el 2022-08-11. [Consulta: 20 juny 2022].

unibas.ch (Global: 9,678^th place; Catalan: low place)

edoc.unibas.ch

«Differential effects of MDMA and methylphenidate on social cognition». Journal of Psychopharmacology, vol. 28, 9, 9-2014, p. 847–56. DOI: 10.1177/0269881114542454. PMID: 25052243.

unodc.org (Global: 2,954^th place; Catalan: 2,929^th place)

World Drug Report 2018. Nacions Unides, Juny 2018, p. 7. ISBN 978-92-1-148304-8.
World Drug Report 2014. Vienna, Austria: United Nations Office on Drugs and Crime, June 2014, p. 2, 3, 123–152. ISBN 978-92-1-056752-7.
«Decision to place MDMA into Schedule I». UNODC. Commission on Narcotic Drugs, 11-02-1986. [Consulta: 9 maig 2015].
«Ecstasy-type substances Retail and wholesale prices* and purity levels, by drug, region and country or territory». United Nations Office on Drugs and Crime. Arxivat de l'original el 2015-12-08. [Consulta: 2 gener 2015].

vice.com (Global: 247^th place; Catalan: 309^th place)

«Watch Out for Pentylone, the Horrible New MDMA Additive». Vice, 04-08-2017.

washingtonpost.com (Global: 35^th place; Catalan: 110^th place)

«Ecstasy could be 'breakthrough' therapy for soldiers, others suffering from PTSD» (en anglès). , 06-08-2017.
«Chemist Alexander Shulgin, popularizer of the drug Ecstasy, dies at 88». WP Company LLC, 03-06-2014.

web.archive.org (Global: 1^st place; Catalan: 1^st place)

«Hva er tryggest av molly og ecstasy?» (en noruec). Ung.no. Norwegian Directorate for Children, Youth and Family Affairs. Arxivat de l'original el 2022-08-11. [Consulta: 20 juny 2022].
«MDMA». Drugs.com. Drugsite Trust, 18-05-2014. Arxivat de l'original el 2016-03-23. [Consulta: 30 març 2016].
«Drug facts: MDMA (Ecstasy/Molly)». National Institute on Drug Abuse, 01-02-2016. Arxivat de l'original el 2016-03-23. [Consulta: 30 març 2016].
«The Agony and Ecstasy of God's path». Consell de Pràctiques Espirituals (CSP), 29-07-1995. Arxivat de l'original el 2013-04-24. [Consulta: 11 juny 2011].
«DrugFacts: MDMA (Ecstasy or Molly)». National Institute on Drug Abuse. Arxivat de l'original el 2014-12-03. [Consulta: 2 desembre 2014].
«Man arrested for possession of ecstasy tablets shaped like Wario». Nintendo Enthusiast, 20-06-2019. Arxivat de l'original el 2021-06-24. [Consulta: 17 juny 2021].
«Early Warning - MDMA and MDA Producers Using Ocotea Cymbarum as a Precursor». DEA Microgram Newsletter. Drug Enforcement Agency, U.S. Department of Justice, vol. 38, 11, 11-11-2005, p. 166. Arxivat 2012-10-18 a Wayback Machine.
E. Merck a Darmstadt. «Patent alemanya 274350: German Patent 274350: Verfahren zur Darstellung von Alkyloxyaryl-, Dialkyloxyaryl- und Alkylendioxyarylaminopropanen bzw. deren am Stickstoff monoalkylierten Derivaten». Kaiserliches Patentamt, 16-05-1914. Arxivat de l'original el 2021-08-28. [Consulta: 12 abril 2009].
Firma E. Merck a Darmstadt. «Patent alemanya 279194: Verfahren zur Darstellung von Hydrastinin Derivaten». Kaiserliches Patentamt, 15-10-1914. Arxivat de l'original el 2021-08-28. [Consulta: 21 març 2024].
«Alexander 'Sasha' Shulgin». Alexander Shulgin Research Institute. Arxivat de l'original el 2014-12-20. [Consulta: 8 gener 2015].
«Ecstasy rising». Primetime Thursday. ABC News, 01-04-2004. Arxivat 2015-05-27 a Wayback Machine.
«Countdown to Ecstasy: A New Drug for a New Millennium». The Austin Chronicle. Weekly Wire, 12-06-2000. Arxivat 2016-01-21 a Wayback Machine.
«Molly Isn't Who You Think She Is: A Deeper Look at MDMA». Playboy. 2013-10-20. Arxivat de l'original el 2015-07-27.
«Bibliografia d'Estudis de Recerca Psicodèlics.». Associació Multidisciplinària d'Estudis Psicodèlics (MAPS). Arxivat de l'original el 2013-12-03.
«Mephedrone (4-Methylmethcathinone) appearing in "Ecstasy" in the Netherlands». , 19-09-2010. Arxivat 2012-11-05 a Wayback Machine.
«Rapport Drugs in Lijsten». Rijksoverheid.nl, 27-06-2011. Arxivat de l'original el 2012-03-06. [Consulta: 29 agost 2012].
«Committee: the current system of the Opium Act does not have to be changed». government.nl, 24-06-2011. Arxivat de l'original el 2012-04-29. [Consulta: 29 agost 2012].
«Schedule I». Controlled Drugs and Substances Act. Isomer Design. Arxivat de l'original el 2013-11-10. [Consulta: 9 desembre 2013].
«Definitions and interpretations». Controlled Drugs and Substances Act. Isomer Design. Arxivat de l'original el 2013-11-10. [Consulta: 9 desembre 2013].
Centre de Vigilància de Drogues i Toxicomanies d'Europa. Annual report: the state of the drugs problem in Europe. Luxemburg: European Monitoring Centre for Drugs and Drug Addiction, 2008, p. 49. ISBN 978-92-9168-324-6. Arxivat 2013-04-25 a Wayback Machine.
European Monitoring Centre for Drugs Drug Addiction. «Ecstasy: high purity powder available». A: European Drug Report, 2014, p. 26. DOI 10.2810/32306. ISBN 978-92-9168-694-0. Arxivat 2014-09-07 a Wayback Machine.
«Ecstasy-type substances Retail and wholesale prices* and purity levels, by drug, region and country or territory». United Nations Office on Drugs and Crime. Arxivat de l'original el 2015-12-08. [Consulta: 2 gener 2015].
«Monitoring of illicit pill distribution networks using an image collection exploration framework». Forensic Science International, vol. 223, 1–3, 11-2012, p. 298–305. DOI: 10.1016/j.forsciint.2012.10.004. PMID: 23107059. Arxivat 2021-08-28 a Wayback Machine.
«10 years of ecstasy and other party drug use in Australia: What have we done and what is there left to do?». Drugtext.org. Arxivat de l'original el 2012-02-09.
«Now sick dealers peddle Shaun the Sheep Ecstasy tablets». Western Daily Press, 31-07-2015. Arxivat de l'original el 2015-08-12. [Consulta: 3 març 2016].

weeklywire.com (Global: low place; Catalan: low place)

«Countdown to Ecstasy: A New Drug for a New Millennium». The Austin Chronicle. Weekly Wire, 12-06-2000. Arxivat 2016-01-21 a Wayback Machine.

westerndailypress.co.uk (Global: low place; Catalan: low place)

«Now sick dealers peddle Shaun the Sheep Ecstasy tablets». Western Daily Press, 31-07-2015. Arxivat de l'original el 2015-08-12. [Consulta: 3 març 2016].

who.int (Global: 213^th place; Catalan: 189^th place)

whqlibdoc.who.int

WHO Expert Committee on Drug Dependence: Twenty-second Report. Ginebra: World Health Organization, 1985, p. 24–25. ISBN 978-9241207294.

wired.com (Global: 254^th place; Catalan: 308^th place)

archive.wired.com

«Professor X». Wired. Sep 2002.

worldcat.org (Global: 4^th place; Catalan: 6^th place)

«Altered brain activity and functional connectivity after MDMA-assisted therapy for post-traumatic stress disorder». Frontiers in Psychiatry, vol. 13, 2023, p. 947622. DOI: 10.3389/fpsyt.2022.947622. ISSN: 1664-0640. PMC: 9879604. PMID: 36713926.
Manual d'Atenció Crítica Americana d'Oxford. Oxford University Press, 2008, p. 464. ISBN 978-0-19-530528-9. OCLC 1003197730.

MDMA (Catalan Wikipedia)

abc.net.au (Global: 120th place; Catalan: 333rd place)

aclu.org (Global: 5,691st place; Catalan: low place)

adsabs.harvard.edu (Global: 14th place; Catalan: 22nd place)

amazon.com (Global: 159th place; Catalan: 306th place)

apnews.com (Global: 101st place; Catalan: 341st place)

archive.org (Global: 6th place; Catalan: 15th place)

archives-ouvertes.fr (Global: 1,143rd place; Catalan: 1,180th place)

hal.archives-ouvertes.fr

bbc.co.uk (Global: 11th place; Catalan: 21st place)

news.bbc.co.uk

bbc.co.uk

books.google.cat (Global: 516th place; Catalan: 3rd place)

cbc.ca (Global: 110th place; Catalan: 319th place)

csp.org (Global: low place; Catalan: low place)

doi.org (Global: 2nd place; Catalan: 4th place)

dx.doi.org

drugabuse.gov (Global: low place; Catalan: low place)

drugs.com (Global: 529th place; Catalan: 330th place)

drugtext.org (Global: low place; Catalan: low place)

erowid.org (Global: 3,273rd place; Catalan: 4,924th place)

espacenet.com (Global: 950th place; Catalan: 1,496th place)

v3.espacenet.com

europa.eu (Global: 62nd place; Catalan: 73rd place)

emcdda.europa.eu

forumclinic.org (Global: low place; Catalan: 4,001st place)

fsijournal.org (Global: low place; Catalan: low place)

gov.bc.ca (Global: 1,686th place; Catalan: 2,028th place)

www2.gov.bc.ca

government.nl (Global: low place; Catalan: low place)

ingentaconnect.com (Global: 3,367th place; Catalan: 1,485th place)

isomerdesign.com (Global: low place; Catalan: low place)

jstor.org (Global: 23rd place; Catalan: 44th place)

justia.com (Global: 673rd place; Catalan: 2,304th place)

law.justia.com

justice.gov (Global: 884th place; Catalan: 1,487th place)

kwtx.com (Global: low place; Catalan: low place)

latimes.com (Global: 32nd place; Catalan: 91st place)

latimes.com

articles.latimes.com

maps.org (Global: low place; Catalan: low place)

medscape.com (Global: 1,078th place; Catalan: 758th place)

emedicine.medscape.com

nbcnews.com (Global: 156th place; Catalan: 447th place)

newspaperarchive.com (Global: 1,148th place; Catalan: 4,707th place)

nih.gov (Global: 5th place; Catalan: 7th place)

ncbi.nlm.nih.gov

toxnet.nlm.nih.gov

nintendoenthusiast.com (Global: low place; Catalan: low place)

nytimes.com (Global: 7th place; Catalan: 14th place)

nytimes.com

artsbeat.blogs.nytimes.com

playboy.com (Global: 4,392nd place; Catalan: 4,515th place)

racgp.org.au (Global: low place; Catalan: low place)

www1.racgp.org.au

researchgate.net (Global: 96th place; Catalan: 89th place)

rijksoverheid.nl (Global: 3,767th place; Catalan: 8,710th place)

science.org (Global: 1,007th place; Catalan: 895th place)

scientopia.org (Global: low place; Catalan: low place)

shulginresearch.org (Global: low place; Catalan: low place)

slp.wa.gov.au (Global: low place; Catalan: low place)

statutelaw.gov.uk (Global: low place; Catalan: low place)

telegraph.co.uk (Global: 40th place; Catalan: 86th place)

thedea.org (Global: low place; Catalan: low place)

thedocumentarygroup.com (Global: low place; Catalan: low place)

theguardian.com (Global: 16th place; Catalan: 29th place)

ung.no (Global: low place; Catalan: low place)

unibas.ch (Global: 9,678th place; Catalan: low place)

edoc.unibas.ch

unodc.org (Global: 2,954th place; Catalan: 2,929th place)

vice.com (Global: 247th place; Catalan: 309th place)

washingtonpost.com (Global: 35th place; Catalan: 110th place)

web.archive.org (Global: 1st place; Catalan: 1st place)

weeklywire.com (Global: low place; Catalan: low place)

westerndailypress.co.uk (Global: low place; Catalan: low place)

who.int (Global: 213th place; Catalan: 189th place)

whqlibdoc.who.int

wired.com (Global: 254th place; Catalan: 308th place)

archive.wired.com

worldcat.org (Global: 4th place; Catalan: 6th place)

abc.net.au (Global: 120^th place; Catalan: 333^rd place)

aclu.org (Global: 5,691^st place; Catalan: low place)

adsabs.harvard.edu (Global: 14^th place; Catalan: 22^nd place)

amazon.com (Global: 159^th place; Catalan: 306^th place)

apnews.com (Global: 101^st place; Catalan: 341^st place)

archive.org (Global: 6^th place; Catalan: 15^th place)

archives-ouvertes.fr (Global: 1,143^rd place; Catalan: 1,180^th place)

bbc.co.uk (Global: 11^th place; Catalan: 21^st place)

books.google.cat (Global: 516^th place; Catalan: 3^rd place)

cbc.ca (Global: 110^th place; Catalan: 319^th place)

doi.org (Global: 2^nd place; Catalan: 4^th place)

drugs.com (Global: 529^th place; Catalan: 330^th place)

erowid.org (Global: 3,273^rd place; Catalan: 4,924^th place)

espacenet.com (Global: 950^th place; Catalan: 1,496^th place)

europa.eu (Global: 62^nd place; Catalan: 73^rd place)

forumclinic.org (Global: low place; Catalan: 4,001^st place)

gov.bc.ca (Global: 1,686^th place; Catalan: 2,028^th place)

ingentaconnect.com (Global: 3,367^th place; Catalan: 1,485^th place)

jstor.org (Global: 23^rd place; Catalan: 44^th place)

justia.com (Global: 673^rd place; Catalan: 2,304^th place)

justice.gov (Global: 884^th place; Catalan: 1,487^th place)

latimes.com (Global: 32^nd place; Catalan: 91^st place)

medscape.com (Global: 1,078^th place; Catalan: 758^th place)

nbcnews.com (Global: 156^th place; Catalan: 447^th place)

newspaperarchive.com (Global: 1,148^th place; Catalan: 4,707^th place)

nih.gov (Global: 5^th place; Catalan: 7^th place)

nytimes.com (Global: 7^th place; Catalan: 14^th place)

playboy.com (Global: 4,392^nd place; Catalan: 4,515^th place)

researchgate.net (Global: 96^th place; Catalan: 89^th place)

rijksoverheid.nl (Global: 3,767^th place; Catalan: 8,710^th place)

science.org (Global: 1,007^th place; Catalan: 895^th place)

telegraph.co.uk (Global: 40^th place; Catalan: 86^th place)

theguardian.com (Global: 16^th place; Catalan: 29^th place)

unibas.ch (Global: 9,678^th place; Catalan: low place)

unodc.org (Global: 2,954^th place; Catalan: 2,929^th place)

vice.com (Global: 247^th place; Catalan: 309^th place)

washingtonpost.com (Global: 35^th place; Catalan: 110^th place)

web.archive.org (Global: 1^st place; Catalan: 1^st place)

who.int (Global: 213^th place; Catalan: 189^th place)

wired.com (Global: 254^th place; Catalan: 308^th place)

worldcat.org (Global: 4^th place; Catalan: 6^th place)